Patents by Inventor Thomas C. McKenzie

Thomas C. McKenzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5260277
    Abstract: Guanidinyl-containing compounds, and related compounds and salts, useful as cell receptor antagonists for modulating cell adhesion via integrin receptors and/or fibronectin receptors, are disclosed. Methods for synthesizing, testing, formulating, and using the compounds as therapeutic agents are also disclosed.
    Type: Grant
    Filed: September 10, 1990
    Date of Patent: November 9, 1993
    Assignee: Tanabe Seiyaku Co., Ltd.
    Inventor: Thomas C. McKenzie
  • Patent number: 4544665
    Abstract: This invention concerns 1-aryl-3-azabicyclo[3.2.0]heptanes and their acid-addition salts. More particularly, this invention pertains to compositions useful for treatment of depression in warm-blooded animals.
    Type: Grant
    Filed: November 21, 1983
    Date of Patent: October 1, 1985
    Assignee: American Cyanamid Company
    Inventors: Joseph W. Epstein, Thomas C. McKenzie, William J. Fanshawe
  • Patent number: 4529736
    Abstract: This disclosure describes 3a-(substituted-phenyl)-2,3,3a,4,7,7a-hexahydro[or 3a-(substituted-phenyl) octahydro]-4,7-alkano-1H-isoindoles which possess activity as antidepressants and as antistress agents in mammals.
    Type: Grant
    Filed: April 6, 1983
    Date of Patent: July 16, 1985
    Assignee: American Cyanamid Company
    Inventors: Thomas C. McKenzie, William J. Fanshawe, Joseph W. Epstein
  • Patent number: 4431661
    Abstract: Novel compounds are disclosed having the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are each individually selected from the class consisting essentially of hydrogen, hydroxy, chloro, bromo, an alkyl radical having up to 3 carbon atoms, an alkoxy radical having up to 3 carbon atoms, and trifluoromethyl, and any two or more of R.sub.1, R.sub.2 and R.sub.3 may be the same; R.sub.4 is selected from the class consisting essentially of hydrogen, an alkyl radical having up to 3 carbon atoms, an allyl radical having up to 4 carbon atoms, the cyclopropylmethyl radical or the phenethyl radical; and W and W' each represent a monovalent alkyl moiety having up to 3 carbon atoms or W-W' jointly represent a divalent moiety of the formula ##STR2## where n is an integer of 2 or 3, including individual optically active isomers, racemic mixtures thereof, and non-toxic pharmacologically-acceptable acid-addition salts thereof. Such compounds are useful as analgesics in mammals.
    Type: Grant
    Filed: August 20, 1981
    Date of Patent: February 14, 1984
    Assignee: American Cyanamid Company
    Inventors: Thomas C. McKenzie, Joseph W. Epstein, William J. Fanshawe
  • Patent number: 4302589
    Abstract: Novel substituted 3-[2-(4-phenyl or pyridyl-1-piperazinyl or piperidino)ethyl]indolines useful as antipsychotic agents in mammals as well as substituted 3-[2-(4-phenylpiperidino)ethyl]indole intermediates for their preparation.
    Type: Grant
    Filed: May 8, 1980
    Date of Patent: November 24, 1981
    Assignee: American Cyanamid Company
    Inventors: William J. Fanshawe, Thomas C. McKenzie, Lantz S. Crawley
  • Patent number: 4221715
    Abstract: Substituted Dibenz[b,f][1,4]oxazepin-11-yl pyridinium salts and derivatives thereof useful as intermediates in the preparation of anti-psychotic agents.
    Type: Grant
    Filed: August 3, 1979
    Date of Patent: September 9, 1980
    Assignee: American Cyanamid Company
    Inventors: Thomas C. McKenzie, Lantz S. Crawley, John J. Brown
  • Patent number: 4221714
    Abstract: Unsubstituted, mono-, di- or trisubstituted-11-(1,2,3,6-tetrahydro-substituted-4-pyridyl)-dibenz[b,f][1 ,4]oxazepines, useful as anti-psychotic agents..
    Type: Grant
    Filed: August 3, 1979
    Date of Patent: September 9, 1980
    Assignee: American Cyanamid Company
    Inventors: Thomas C. McKenzie, John J. Brown